These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2140533)

  • 1. Further characterization of murine bone marrow-derived natural suppressor cells. Potential relationships between NS and NK/LAK activities.
    Saffran DC; Singhal SK
    Cell Immunol; 1990 Jun; 128(1):301-13. PubMed ID: 2140533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of allostimulatory and natural suppressor/stem cell functions of murine bone marrow--implications for bone marrow transplantation.
    Saffran DC; Parsons MF; Singhal SK
    Transplantation; 1991 Oct; 52(4):680-4. PubMed ID: 1833866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of a splenic cytotoxic effector cell in mice of genotype SCID/SCID.BG/BG.
    MacDougall JR; Croy BA; Chapeau C; Clark DA
    Cell Immunol; 1990 Oct; 130(1):106-17. PubMed ID: 2144467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lymphokine-activated killer cells as mediators of veto and natural suppression.
    Azuma E; Kaplan J
    J Immunol; 1988 Oct; 141(8):2601-6. PubMed ID: 3171179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine natural suppressor cells in the newborn, in bone marrow, and after cyclophosphamide. Genetic variations and dependence on IFN-gamma.
    Maier T; Holda JH; Claman HN
    J Immunol; 1989 Jul; 143(2):491-8. PubMed ID: 2525587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures.
    van den Brink MR; Boggs SS; Herberman RB; Hiserodt JC
    J Exp Med; 1990 Jul; 172(1):303-13. PubMed ID: 2358779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous alloreactivity of natural killer (NK) and lymphokine-activated killer (LAK) cells from athymic rats against normal haemic cells. NK cells stimulate syngeneic but inhibit allogeneic haemopoiesis.
    Rolstad B; Benestad HB
    Immunology; 1991 Sep; 74(1):86-93. PubMed ID: 1937576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of murine lymphokine-activated killer cells by recombinant IL-7.
    Lynch DH; Miller RE
    J Immunol; 1990 Sep; 145(6):1983-90. PubMed ID: 1975262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector and precursor phenotypes of lymphokine-activated killer cells in mice with severe combined immunodeficiency (scid) and athymic (nude) mice.
    Hasui M; Saikawa Y; Miura M; Takano N; Ueno Y; Yachie A; Miyawaki T; Taniguchi N
    Cell Immunol; 1989 Apr; 120(1):230-9. PubMed ID: 2784720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphokine-activated killer cells in rats: generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells.
    Sarneva M; Vujanovic NL; Van den Brink MR; Herberman RB; Hiserodt JC
    Cell Immunol; 1989 Feb; 118(2):448-57. PubMed ID: 2910504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.
    Vujanovic NL; Herberman RB; Hiserodt JC
    Cancer Res; 1988 Feb; 48(4):878-83. PubMed ID: 3257411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow.
    Drobyski WR; Piaskowski V; Ash RC; Casper JT; Truitt RL
    Transplantation; 1990 Oct; 50(4):625-32. PubMed ID: 1699309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of linked suppression in addition to the donor H-2 class I-specific unresponsiveness in recipient T cells by transfusing class I plus class II-disparate, but not class I alone-disparate, bone marrow cells.
    Muraoka S
    Cell Immunol; 1990 Jun; 128(1):261-76. PubMed ID: 1971530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma.
    Maier T; Holda JH
    J Immunol; 1987 Jun; 138(12):4075-84. PubMed ID: 2953798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of purified adherent lymphokine-activated killer cells in mice.
    Gunji Y; Vujanovic NL; Hiserodt JC; Herberman RB; Gorelik E
    J Immunol; 1989 Mar; 142(5):1748-54. PubMed ID: 2783950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Gillio A
    Cell Immunol; 1990 Mar; 126(1):211-26. PubMed ID: 1689220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of nitric oxide in bone marrow-derived natural suppressor activity. Its dependence on IFN-gamma.
    Angulo I; Rodríguez R; García B; Medina M; Navarro J; Subiza JL
    J Immunol; 1995 Jul; 155(1):15-26. PubMed ID: 7541413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.